NCT04779164|CompletedDMC
Loading search results
Sponsor study identifier
interventional
126
1 country
1
Study Start
September 4, 2020
Actual (reported)Primary Completion
October 30, 2020
Actual (reported)Study Completion
October 30, 2020
Actual (reported)Background:Knee osteoarthritis is more common in patients with type-2 diabetes mellitus, however it is not known whether this effect is caused by diabetes itself or concominant abdominal obesity. Objectives:The aim of this study is to determine whether type-2 diabetes itself, independent of abdominal obesity, is a risk factor for femoral cartilage, knee osteoarthritis and poor quality of life. Design:A cross-sectional design. Settings:Training and research hospital in Turkey. Patients and Methods:Female patients was enrolled in this study and divided into two groups: according to presence or absence of diabetes. Later, both the patients with and without abdominal obesity was divided into two groups according the presence of diabetes. Main Outcome measures:Clinical parameters were visual analog-scale, gait speed and short form-36. Knee radiographs were evaluated according to Kellgren Lawrance-Scale. And ultrasonography parameters were the measurements of distal femoral cartilage thickness. Sample size:126
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 30, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 4, 2020
Actual (reported)October 30, 2020
Actual (reported)October 30, 2020
Actual (reported)February 25, 2021
Actual (reported)March 3, 2021
Actual (reported)Femoral cartilage thickness
Measured by ultrasonography (higher value:thick cartilage, lower value:thin cartilage)
baseline
visual analog scale
baseline
radiographic knee osteoarthritis
baseline
Patients with diabetes mellitus was evaluated in terms of pain scores and ultrasonographic femoral cartilage thickness and retrospective radiographic knee osteoarthritis scores.
Patients without diabetes mellitus was evaluated in terms of pain scores and ultrasonographic femoral cartilage thickness and retrospective radiographic knee osteoarthritis scores.
The knees of all patients were screened with ultrasonography device for the measurement of femoral cartilage thicknesses.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Eskişehir City Hospital
Eskişehir, Turkey (Türkiye)
Fulya Bakılan
Eskisehir City Hospital
126 participants (actual enrollment reported by the registry).
First Submitted
February 25, 2021
First Posted
March 3, 2021
Study Start
September 4, 2020
Is Isokinetic Testing an Indicator of Total Knee Arthroplasty
Contact the study team to confirm eligibility.
Primary Completion
October 30, 2020
Actual (reported)Study Completion
October 30, 2020
Actual (reported)Last Updated
March 3, 2021
Record last verified: 2021-02
1 year later
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: